Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aqua Metals, Inc.AQMS · Entity 7979 | Director | January 03, 2020 | January 08, 2020 |
| ClearSign Technologies CorpCLIR · Entity 7487 | Director | January 03, 2023 | January 05, 2023 |
| Flyte Aviation, Inc.RMED · Entity 8648 | Director | January 09, 2023 | March 27, 2023 |
| MDB Capital Holdings, LLCMDBH · Entity 7469 | Director | August 14, 2025 | December 23, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aqua Metals, Inc.
Report date January 03, 2020 · Filed January 08, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-03-31 | Direct | 20,378 |
Reported balance
After 2020-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-03 · Grant · Acquired 20,378 · Balance 20,378 F1: Includes 20,378 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. All RSUs shall be settled in common shares only and will vest and be delivered on March 31, 2020. F2: In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of RSUs, the "class" of derivative security reported in Column 1. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 20,378 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. All RSUs shall be settled in common shares only and will vest and be delivered on March 31, 2020.
F2: In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of RSUs, the "class" of derivative security reported in Column 1.
ClearSign Technologies Corp
Report date January 03, 2023 · Filed January 05, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 42,870 |
Reported balance
After 2023-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-03 · Grant · Acquired 42,870 · Balance 42,870 F1: As compensation for services as a non-executive director during the quarter ending March 31, 2023, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 24,088 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 24,088 F3: As compensation for services as a non-executive director during the quarter ended December 31, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,820 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 19,820 F4: As compensation for services as a non-executive director during the quarter ended September 30, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,090 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 14,090 F5: As compensation for services as a non-executive director during the quarter ended June 30, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 16,145 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 16,145 F6: As compensation for services as a non-executive director during the quarter ended March 31, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,531 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,531 F7: As compensation for services as a non-executive director during the quarter ended December 31, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,017 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 8,017 F8: As compensation for services as a non-executive director during the quarter ended September 30, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,017 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 8,017 F9: As compensation for services as a non-executive director during the quarter ended June 30, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $3.97 · Expires 2031-01-21 | Direct | 22,750 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 22,750 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.38 · Expires 2030-11-18 | Direct | 22,750 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 22,750 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.30 · Expires 2030-05-17 | Direct | 22,750 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 22,750 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.54 · Expires 2030-05-19 | Direct | 22,750 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 22,750 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.72 · Expires 2030-04-01 | Direct | 22,750 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 22,750 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2029-04-01 | Direct | 91,000 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 91,000 F10: The right to exercise the option and purchase the option shares vested in equal increments as follows: the right to purchase 22,750 shares vested on May 9, 2019 and the right to purchase the remaining 68,250 shares vested in equal increments on the last day of each calendar quarter during 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: As compensation for services as a non-executive director during the quarter ending March 31, 2023, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F2: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service.
F3: As compensation for services as a non-executive director during the quarter ended December 31, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F4: As compensation for services as a non-executive director during the quarter ended September 30, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F5: As compensation for services as a non-executive director during the quarter ended June 30, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F6: As compensation for services as a non-executive director during the quarter ended March 31, 2022, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F7: As compensation for services as a non-executive director during the quarter ended December 31, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F8: As compensation for services as a non-executive director during the quarter ended September 30, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F9: As compensation for services as a non-executive director during the quarter ended June 30, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof.
F10: The right to exercise the option and purchase the option shares vested in equal increments as follows: the right to purchase 22,750 shares vested on May 9, 2019 and the right to purchase the remaining 68,250 shares vested in equal increments on the last day of each calendar quarter during 2019.
Flyte Aviation, Inc.
Report date January 09, 2023 · Filed March 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 2,575 |
Reported balance
After 2023-03-23 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-03-23 · Conversion · Acquired 2,575 · Balance 2,575 F1: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. |
| Series X Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 14.056 |
Reported balance
After 2023-01-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-09 · Grant · Acquired 14.056 · Balance 14.056 F3: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F4: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000). F5: Series X Convertible Preferred Stock has no expiration date. |
| Series X Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectBy Spouse | 11.481 |
Reported balance
After 2023-03-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-23 · Conversion · Disposed 2.575 · Balance 11.481 F1: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. F5: Series X Convertible Preferred Stock has no expiration date. |
| Common StockSEC Table I · non-derivative | Direct | 36 |
Reported balance
Holding disclosure · report date 2023-01-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 36 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 800 |
Reported balance
Holding disclosure · report date 2023-01-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 800 F2: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.
F2: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein.
F3: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.
F4: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).
F5: Series X Convertible Preferred Stock has no expiration date.
MDB Capital Holdings, LLC
Report date August 14, 2025 · Filed December 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,000 |
Reported balance
After 2025-08-14 transaction · row 1
1 source rowRow 1 · 2025-08-14 · Exercise / conversion · Acquired 10,000 · Balance 30,000 |
| RSUSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-08-14 | Direct | 70,000 |
Reported balance
After 2025-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-08-14 · Exercise / conversion · Acquired 10,000 · Balance 70,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2025 Filed Dec 23, 2025 16:32 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionRSU · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-029059 · ownership.xml · derivative · entry 2 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Class A · 10,000 shares Expires 2025-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2025 Filed Dec 23, 2025 16:32 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionCommon Stock | 10,000 | $3.40 | $34,000.00 |
DisclosureSEC source: 0001493152-25-029059 · ownership.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 12:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionRSU · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-050948 · ownership.xml · derivative · entry 2 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A · 20,000 shares Expires 2024-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 12:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionCommon Stock | 20,000 | $6.81 | $136,200.00 |
DisclosureSEC source: 0001493152-24-050948 · ownership.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 21:22 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | ConversionSeries X Convertible Preferred Stock · Derivative | 2.575 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003617 · section16.xml · derivative · entry 5 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 11.481 Underlying: Common Stock · 11,481 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 21:22 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | ConversionCommon Stock | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003617 · section16.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 2,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This the transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval. Read SEC document |
| January 09, 2023 Filed Mar 27, 2023 21:22 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantSeries X Convertible Preferred Stock · Derivative | 14.056 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-003617 · section16.xml · derivative · entry 4 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 14.056 Underlying: Common Stock · 14,056 shares Expires not disclosed F3 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F4 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000). F3 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 01:20 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 42,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001058 · tm231746-2_4seq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,870 Underlying: Common Stock · 42,870 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending March 31, 2023, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 20:33 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 24,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-105891 · tm2227432-3_4seq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,088 Underlying: Common Stock · 24,088 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending December 31, 2022, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 22:32 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 19,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-077802 · tm2220508-1_4seq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,820 Underlying: Common Stock · 19,820 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending September 30, 2022, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:29 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 14,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-042379 · tm2211527-3_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,090 Underlying: Common Stock · 14,090 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending June 30, 2022, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 02:41 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 16,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001688 · tm221817d4_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,145 Underlying: Common Stock · 16,145 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending March 31, 2022, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 23:56 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 14,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-141383 · tm2133431-4_4seq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,531 Underlying: Common Stock · 14,531 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending December 31, 2021, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 20:36 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 8,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-109830 · tm2125932d1_4seq1.xml · derivative · entry 2 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,017 Underlying: Common Stock · 8,017 shares Expires not disclosed F3 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ending September 30, 2021, the reporting person was granted RSUs under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 20:36 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantRestricted Stock Units · Derivative | 8,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-109830 · tm2125932d1_4seq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,017 Underlying: Common Stock · 8,017 shares Expires not disclosed F1 · derivative.exercise_price: As compensation for services as a non-executive director during the quarter ended June 30, 2021, the reporting person was granted restricted stock units ("RSUs") under the ClearSign Technologies Corporation 2021 Equity Incentive Plan and each RSU represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. F2 · derivative.expiration_date: The RSUs will vest upon the first to occur of: (1) a Change in Control (as defined in the applicable RSU award agreement), (2) the reporting person's Disability (as defined in the applicable RSU award agreement); (3) the reporting peron's death; or (4) the reporting person's separation from service. Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 00:08 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039056 · doc4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,808 F1 · shares: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 01:07 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008326 · doc4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. The RSUs shall vest annually over a four year period, beginning on January 31, 2021, so that the RSUs will be fully vested on January 31, 2025, subject to the reporting person's continued service through each such vesting date. Read SEC document |
| January 22, 2021 Filed Jan 25, 2021 22:59 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $3.97 | $0.00 |
DisclosureSEC source: 0001104659-21-007293 · tm214006d3_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2031-01-21 F1 · security: On January 22, 2021, the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the period from January 1, 2021 to March 31, 2021. The reporting person is a non-executive director. As compensation for their services, each non-executive director was awarded options for shares of common stock having an exercise price of $3.97. The options fully vest on April 1, 2021, subject to the reporting person's continued service as a non-executive director to the Issuer. The total numbers of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The award was recommended to the Issuer's board of directors by its compensation committee and issued from the Issuer's 2011 Equity Incentive Plan. F1 · derivative.exercise_date: On January 22, 2021, the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the period from January 1, 2021 to March 31, 2021. The reporting person is a non-executive director. As compensation for their services, each non-executive director was awarded options for shares of common stock having an exercise price of $3.97. The options fully vest on April 1, 2021, subject to the reporting person's continued service as a non-executive director to the Issuer. The total numbers of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The award was recommended to the Issuer's board of directors by its compensation committee and issued from the Issuer's 2011 Equity Incentive Plan. Read SEC document |
| November 19, 2020 Filed Nov 23, 2020 21:03 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001104659-20-128455 · tm2036637d3_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2020-11-18 F1 · security: On November 19, 2020 the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the period from October 1, 2020 to December 31, 2020. The reporting person is a non-executive director. As compensation for their services, each non- executive director was awarded options for shares of common stock having an exercise price of $2.38. The total numbers of option shares awarded was based on the services provided by the director. These services include board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The award was issued from the Issuer's 2011 Equity Incentive Plan. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:01 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | PurchaseCommon Stock/CLIR | 5,000 | $2.00 | $10,000.00 |
DisclosureSEC source: 0001104659-20-098675 · tm2029421d2_4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,249 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:51 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001104659-20-097274 · tm2029083-2_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2030-08-17 F1 · security: On August 18, 2020 the Issuer's Board of Directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the period from July 1, 2020 to September 30, 2020. The reporting person is a non-executive director. As compensation for their services, each non- executive director was awarded options for shares of common stock having an exercise price of $2.30. The total numbers of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The award was issued from the Issuer's 2011 Equity Incentive Plan. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:30 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001104659-20-064281 · tm2020299d3_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2030-05-18 F1 · security: On May 18, 2020 the Compensation Committee of the Issuer's board of directors, in accordance with a compensation policy approved by the board of directors, approved compensation to be paid to the Issuer's non-executive directors for services provided and to be provided to the Issuer during the period from April 1, 2020 to June 30, 2020. The reporting person is a non-executive director. As compensation for their services, each non- executive director was awarded options for shares of common stock having an exercise price of $0.54. The total number of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The award was issued from the Issuer's 2011 Equity Incentive Plan. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 22:33 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001104659-20-043279 · tm2014958-4_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2030-04-01 F1 · security: On April 1, 2020 the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the period from January 1, 2020 to March 31, 2020. The reporting person is a non-executive director. As compensation for their services, each non-executive director was awarded options for shares of common stock having an exercise price of $0.72. The total number of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The option was issued from the Issuer's 2011 Equity Incentive Plan. The right to exercise the option and purchase the option shares vested on the date of award. Read SEC document |
| January 03, 2020 Filed Jan 8, 2020 01:15 UTC | Aqua Metals, Inc. AQMS · Entity 7979 | GrantRestricted Share Units · Derivative | 20,378 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001621832-20-000018 · wf-form4_157844612124687.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,378 Underlying: Common Shares · 20,378 shares Expires 2025-03-31 F1 · shares: Includes 20,378 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. All RSUs shall be settled in common shares only and will vest and be delivered on March 31, 2020. F2 · balance_after: In accordance with Instruction 4 to this Form, Column 9 reports only total beneficial ownership of RSUs, the "class" of derivative security reported in Column 1. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 21:41 UTC | Aqua Metals, Inc. AQMS · Entity 7979 | GrantRestricted Share Units · Derivative | 8,824 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001621832-19-000105 · wf-form4_157022526004359.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,824 Underlying: Common Shares · 8,824 shares Expires 2023-12-31 F1 · shares: Includes 8,824 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. All RSUs shall be settled in common shares only and will vest and be delivered on December 31, 2019. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 15:42 UTC | Aqua Metals, Inc. AQMS · Entity 7979 | PurchaseCommon Shares | 2,000 | $1.55 | $3,096.80 |
DisclosureSEC source: 0001621832-19-000084 · wf-form4_156527892164677.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,317 F1 · balance_after: Includes 9,317 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. All RSUs shall be settled in common shares only and will vest and be delivered on September 30, 2019. Read SEC document |
| July 03, 2019 Filed Jul 9, 2019 00:15 UTC | Aqua Metals, Inc. AQMS · Entity 7979 | GrantCommon Shares | 9,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001621832-19-000068 · wf-form4_156263133457780.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,317 Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 21:23 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001144204-19-033825 · tv524823_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,500 Underlying: Common Stock · 22,750 shares Expires 2029-04-01 F1 · date: On May 9, 2019 the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during 2019. The reporting person is an non-executive director. As compensation for their services, each non-executive director was awarded options for shares of common stock having an exercise price of $1.00. The total number of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilites and lead director responsibilities, if any. The right to purchase the common stock is earned in quarterly increments. The option was issued from the Company's 2011 Equity Incentive Plan. Read SEC document |
| May 09, 2019 Filed May 13, 2019 22:47 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 22,750 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001144204-19-025696 · tv521422_4.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,750 Underlying: Common Stock · 22,750 shares Expires 2029-04-01 F1 · derivative.exercise_date: On May 9, 2019, the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during the first quarter of 2019. The reporting person is a non-executive director. The number of option shares awarded was based on the services provided by the director. These services include, depending on the individual, Board participation, committee participation, committee chair responsibilities and lead director responsibilities, if any. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. Read SEC document |
| May 09, 2019 Filed Oct 31, 2019 20:31 UTC Amendment | ClearSign Technologies Corp CLIR · Entity 7487 | GrantOption to Purchase Common Stock · Derivative | 91,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001104659-19-058382 · tm1921550-5_4aseq1.xml · derivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,000 Underlying: Common Stock · 91,000 shares Expires 2029-04-01 F1 · derivative.exercise_date: On May 9, 2019 the Issuer's board of directors approved compensation to be paid to the Issuer's non-executive directors for services provided to the Issuer during 2019. The reporting person is an non-executive director. As compensation for their services, each non-executive director was awarded options for shares of common stock having an exercise price of $1.00. The total number of option shares awarded was based on the services provided by the director. These services include Board participation, committee participation, committee chair responsibilites and lead director responsibilities, if any. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. The right to purchase the option shares vests in equal increments as follows: the right to purchase 22,750 shares vested on May 9, 2019 and the right to purchase the remaining 68,250 shares will vest in equal increments on the last day of each calendar quarter. Read SEC document |
| December 31, 2018 Filed Jan 5, 2019 01:07 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantCommon Stock/CLIR | 6,756 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-19-000736 · tv510453_4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,249 F1 · shares: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's non-executive directors. The reporting person is a non-executive director. As partial compensation for services provided to the Issuer during 2018, each non-executive director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. F1 · price: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's non-executive directors. The reporting person is a non-executive director. As partial compensation for services provided to the Issuer during 2018, each non-executive director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 23:00 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantCommon Stock/CLIR | 6,757 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-052152 · tv504084_4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,493 F1 · shares: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's independent directors. The reporting person is an independent director. As partial compensation for services provided to the Issuer during 2018, each independent director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. F1 · price: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's independent directors. The reporting person is an independent director. As partial compensation for services provided to the Issuer during 2018, each independent director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 19:07 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | GrantCommon Stock/CLIR | 13,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-037200 · tv497942_4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,736 F1 · shares: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's independent directors. The reporting person is an independent director. As partial compensation for services provided to the Issuer during 2018, each independent director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. Because the grant was approved in the second quarter, the shares of common stock for both the first and second quarter of 2018 were issued on June 29, 2018. F1 · price: On May 3, 2018 the Issuer's board of directors approved annual compensation for the Issuer's independent directors. The reporting person is an independent director. As partial compensation for services provided to the Issuer during 2018, each independent director was granted 27,027 shares of common stock having a per share value of $1.85, the closing price of the Issuer's common stock on the date of grant. The common stock is earned in quarterly increments and is issued on the last business day of each calendar quarter. The shares of common stock are issued from the Company's 2011 Equity Incentive Plan. Because the grant was approved in the second quarter, the shares of common stock for both the first and second quarter of 2018 were issued on June 29, 2018. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:31 UTC | ClearSign Technologies Corp CLIR · Entity 7487 | PurchaseCommon Stock/CLIR | 22,222 | $2.25 | $49,999.50 |
DisclosureSEC source: 0001144204-18-011796 · tv487222_4.xml · nonDerivative · entry 1 Meline Susanne · CIK 0001731684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,222 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.